eLifeBiophysicsPeer-reviewed journal article
Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2
Siyu CheniD, Tamar BasiashviliiD, Joshua HutchingsiD, Marta M. Sanz MurilloiD, Amalia C. Villagran SuareziD, Erica XiongiD, Jaime Alegrio LouroiD, Andrés E. LeschzineriD, Elizabeth VillaiD
Abstract
Parkinsons Disease (PD) is the second most common neurodegenerative disorder. Mutations in leucine-rich repeat kinase 2 (LRRK2), a multi-domain protein containing both a kinase and a GTPase, are a leading cause of the familial form of PD. Pathogenic LRRK2 mutations increase LRRK2 kinase activity. While the bulk of LRRK2 is found in the cytosol, the protein associates with membranes where its Rab GTPase substrates are found, and under certain conditions, with microtubules. Integrative structural studies using single-particle cryo-electron microscopy (cryo-EM) and in situ cryo-electron tomography (cryo-ET) have revealed the architecture of microtubule-associated LRRK2 filaments, and that formation of these filaments requires LRRK2s kinase to be in the active-like conformation. However, whether LRRK2 can interact with and form filaments on microtubules in its autoinhibited state, where the kinase domain is in the inactive conformation and the N-terminal LRR domain covers the kinase active site, was not known. Using cryo-ET, we show that full-length LRRK2 can oligomerize on microtubules in its autoinhibited state. Both WT-LRRK2 and PD-linked LRRK2 mutants formed filaments on microtubules. While these filaments are stabilized by the same interfaces seen in the active-LRRK2 filaments, we observed a new interface involving the N-terminal repeats that were disordered in the active-LRRK2 filaments. The helical parameters of the autoinhibited-LRRK2 filaments are different from those reported for the active-LRRK2 filaments. Finally, the autoinhibited-LRRK2 filaments are shorter and less regular, suggesting they are less stable.
- organism: human
- assay: cryo-EM
- research focus: protein folding & dynamics
- approach: microscopy & imaging analysis
- Citations
- 12
- FWCI
- 3.00
- Field percentile
- top 8%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The in situ structure of Parkinson’s disease-linked LRRK2
R. Watanabe, R. Buschauer, … E. Villa·bioRxiv·Nov 10, 2019
- In-cell cryo-electron tomography reveals differential effects of type I and type II kinase inhibitors on LRRK2 filament formation and microtubule association
Tamar Basiashvili, Joshua Hutchings, … Elizabeth Villa·bioRxiv·May 28, 2026
- Structural basis for Parkinson's Disease-linked LRRK2's binding to microtubules
D. M. Snead, M. Matyszewski, … S. L. Reck-Peterson·bioRxiv·Jan 21, 2022
- Parkinson's Disease-linked LRRK2 structure and model for microtubule interaction
C. K. Deniston, J. Salogiannis, … A. E. Leschziner·bioRxiv·Jan 6, 2020
- 14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state
Juliana A. Martinez Fiesco, Alexandra G. Beilina, … Ping Zhang·Nature CommunicationsPeer-reviewed·Aug 5, 2025
- The structural basis for LRRK2's activation and autoinhibition
Amalia C. Villagran Suarez, Kathryn S. Hatch, … Andrés E. Leschziner·CellPeer-reviewed·Aug 10, 2026